These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33438083)

  • 21. Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.
    Ahmad S; Kew KM; Normansell R
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011306. PubMed ID: 26089258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
    Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Kew KM; Mavergames C; Walters JA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: A meta-analysis.
    Guo J; Chen Y; Zhang W; Tong S; Dong J
    Int J Surg; 2020 Jun; 78():28-35. PubMed ID: 32304896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temperature-controlled Laminar Airflow (TLA) in symptomatic severe asthma - a post hoc analysis of severe exacerbations, quality of life and health economics.
    Chauhan AJ; Eriksson G; Storrar W; Brown T; Peterson S; Radner F; D'Cruz LG; Miller P; Bjermer L
    BMC Pulm Med; 2022 Nov; 22(1):407. PubMed ID: 36352399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.
    Burch J; Griffin S; McKenna C; Walker S; Paton J; Wright K; Woolacott N
    Pharmacoeconomics; 2012 Nov; 30(11):991-1004. PubMed ID: 22950547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
    Harrison TW; Chanez P; Menzella F; Canonica GW; Louis R; Cosio BG; Lugogo NL; Mohan A; Burden A; McDermott L; Garcia Gil E; Zangrilli JG;
    Lancet Respir Med; 2021 Mar; 9(3):260-274. PubMed ID: 33357499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interventions for managing asthma in pregnancy.
    Bain E; Pierides KL; Clifton VL; Hodyl NA; Stark MJ; Crowther CA; Middleton P
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010660. PubMed ID: 25331331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics.
    Crossman-Barnes CJ; Sach T; Wilson A; Barton G
    Qual Life Res; 2020 Mar; 29(3):619-627. PubMed ID: 31676971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extrafine triple therapy and asthma exacerbation seasonality: TRIMARAN and TRIGGER post hoc analyses.
    Papi A; Virchow JC; Singh D; Kots M; Vele A; Georges G; Canonica GW
    J Allergy Clin Immunol; 2021 Jul; 148(1):262-265.e2. PubMed ID: 33485959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
    Kew KM; Karner C; Mindus SM; Ferrara G
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD009019. PubMed ID: 24343671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study.
    Brusselle G; Michils A; Louis R; Dupont L; Van de Maele B; Delobbe A; Pilette C; Lee CS; Gurdain S; Vancayzeele S; Lecomte P; Hermans C; MacDonald K; Song M; Abraham I
    Respir Med; 2009 Nov; 103(11):1633-42. PubMed ID: 19619998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
    Lee LA; Bailes Z; Barnes N; Boulet LP; Edwards D; Fowler A; Hanania NA; Kerstjens HAM; Kerwin E; Nathan R; Oppenheimer J; Papi A; Pascoe S; Brusselle G; Peachey G; Sule N; Tabberer M; Pavord ID
    Lancet Respir Med; 2021 Jan; 9(1):69-84. PubMed ID: 32918892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Chauhan BF; Ducharme FM
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
    Watz H; Tetzlaff K; Magnussen H; Mueller A; Rodriguez-Roisin R; Wouters EFM; Vogelmeier C; Calverley PMA
    Respir Res; 2018 Dec; 19(1):251. PubMed ID: 30545350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-IL-5 therapies for asthma.
    Farne HA; Wilson A; Milan S; Banchoff E; Yang F; Powell CV
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD010834. PubMed ID: 35838542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Nannini LJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vilanterol and fluticasone furoate for asthma.
    Dwan K; Milan SJ; Bax L; Walters N; Powell C
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010758. PubMed ID: 27582089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.